aid: allorion-therapeutics
name: Allorion Therapeutics
image: https://alloriontx.com/wp-content/uploads/2024/02/Allorion_Logo_web.png
description: 'Allorion Therapeutics is a clinical-stage biopharmaceutical company founded in 2020
  by Qiang Ding and Fang Li, developing novel small-molecule therapies for cancer and autoimmune
  disease. Operating from Natick, Massachusetts and Guangzhou, China, Allorion applies mutant-selective
  and isoform-specific medicinal chemistry across a pipeline that includes ARTS-011 (a TYK2 inhibitor),
  ARTS-021 (a CDK2 inhibitor targeting CCNE1-amplified tumors), and ARTS-023/AVZO-023 partnered with
  Avenzo Therapeutics, alongside an exclusive option and global license agreement with AstraZeneca for
  an allosteric EGFR L858R inhibitor. The company is a drug-discovery organization backed by Qiming
  Venture Partners and INCE Capital; it markets internal data and high-throughput screening platforms
  but publishes no public developer program, API, SDK, or machine-readable specification.'
url: https://raw.githubusercontent.com/api-evangelist/allorion-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Oncology
- Autoimmune
- Life Sciences
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/allorion-therapeutics-domain-security.yml
- type: WellKnown
  url: well-known/allorion-therapeutics-well-known.yml
- type: LLMsTxt
  url: llms/allorion-therapeutics-llms.txt
- type: Website
  url: https://alloriontx.com/
- type: About
  url: https://alloriontx.com/overview/
- type: Team
  url: https://alloriontx.com/our-team/
- type: Pipeline
  url: https://alloriontx.com/pipeline/
- type: Presentations
  url: https://alloriontx.com/presentations/
- type: News
  url: https://alloriontx.com/news/
- type: Careers
  url: https://alloriontx.com/careers/
- type: Contact
  url: https://alloriontx.com/contact/
- type: LinkedIn
  url: https://www.linkedin.com/company/alloriontx/
- type: Twitter
  url: https://twitter.com/AllorionT
- type: SecondaryMarket
  url: https://www.nasdaqprivatemarket.com/
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Allorion Therapeutics is a clinical-stage small-molecule drug-discovery company whose only web
    surface is an eight-page WordPress corporate site (Overview, Team, Pipeline, Presentations,
    News, Careers, Contact) — no api., developer., docs., dev., portal. or app. host resolves for
    alloriontx.com, no allorion/alloriontx/allorion-therapeutics GitHub organisation exists, and
    /openapi.json, /swagger.json, /graphql, /.well-known/agent-card.json, /.well-known/agent.json,
    /.well-known/security.txt and /.well-known/api-catalog all resolve to the site's WordPress 404
    page behind a SiteGround CAPTCHA interstitial that answers every automated request with HTTP
    202.
  evidence:
  - url: https://alloriontx.com/openapi.json
    status: 404
  - url: https://alloriontx.com/.well-known/agent-card.json
    status: 404
  - url: https://alloriontx.com/.well-known/agent.json
    status: 404
  - url: https://alloriontx.com/graphql
    status: 404
  - url: https://api.github.com/orgs/alloriontx
    status: 404
  checked: '2026-08-06'